Entrar/Registro  
HOME SPANISH
 
Acta Pediátrica de México
   
MENU

Contents by Year, Volume and Issue

Table of Contents

General Information

Instructions for Authors

Message to Editor

Editorial Board






>Journals >Acta Pediátrica de México >Year 2006, Issue 1


Vázquez TO, Campos RT
Candidiasis
Acta Pediatr Mex 2006; 27 (1)

Language: Español
References: 40
Page: 30-35
PDF: 60.35 Kb.


Full text




ABSTRACT

This paper reviews the clinical features and operational definitions of candidemia, fungemia, transitory candidemia, acute disseminated candidemia and chronic disseminated candidiasis. The clinical, laboratory and image diagnosis and management of acute and chronic disseminated candidiasis are discussed.


Key words: Candidemia, fungemia, transitory candidemia, acute disseminated candidiasis, chronic disseminated candidiasis.


REFERENCIAS

  1. Rippon J. Tratado de Micología Médica. 3ª ed. Interamericana McGraw-Hill. México 1993;pp:668-703.

  2. Wright WL, Wenzel RP. Nosocomial candida. Infectious diseases. Clin North Am Nosocomial Infections. WB Saunders Co. Philadelphia 1997;11:211-25.

  3. Walsh TJ, González C, Lyman AC, et al. Invasive fungal infections in children: In: Advances in Pediatric Infectious Diseases. Mosby-Year Book Inc. 1996;p204.

  4. Bailey JE. Neonatal candidiasis. The current challenge. Clin Perinatol 1991;18:263-80.

  5. Jones MJ. Laboratory diagnosis of invasive candidiasis. Clin Microbiol Rev 1990;3:32-45.

  6. Hughes WT. Candidiasis. In: Fegin RD. Textbook of Pediatric Infectious Diseases. WB Saunders Co. 1997;pp1814-22.

  7. Montes LF, Wilborn WH. Fungus host relationship in candidiasis. A brief review. Arch Dermatol 1985;121:119-24.

  8. Meunier F, Aoun M, Bitar N. Fungal infections in immunocompromised hosts. CID 1992;14(Sup1):120-5.

  9. Thomas JW, John HR. Infectious Disease. Clinics of North America. Fungal Infections, Part I: Recent Advances in Diagnosis, Treatment, and Prevention of Opportunistic Mycoses. Volume 16. Number 4. December 2002.

  10. Vázquez Tsuji O, Campos Rivera T, Martínez Barbabosa I, de Colsa Ranero A, Mata Rivera N, Ruiz García M, García Camacho G, Álvarez Chacón A, Wong Chio M, Lemus H. Micosis Profundas y Oportunistas. En: Infectología Clínica Pediátrica. Ed. McGraw-Hill Interamericana 2003;pp981-1025.

  11. Sobel DJ. Candiduria. En: Scholssberg D. Current Therapy of Infectious Diseases. Mosby USA. 1996;p194.

  12. Kontoyoannis DP, Luna MA, Samuels BI, Bodey GP. Hepatosplenic candidiasis: a manifestation of chronic disseminated candidiasis. Infect Dis Clin North Am 2000;14:721-39.

  13. Edwards Jr JE, Lehrer RI, Stiehm ER, Fischer TJ, Young LS. Severe candidal infections: clinical perspective, immune defense mechanisms, and current concepts of therapy. Ann Intermed 1978; 89:91-106.

  14. Karp JE, Merz WG, Dick JD. Infection in the neutropenic patient. In: Current Therapy of Infectious Disease. David Scholossberg. Mosby Co. USA 1996;pp268-73.

  15. Kiehn TE, Wong B, Edwards FF, Armstrong D. Comparative recovery of bacteria and yeasts from lysis-centrifugation and a conventional blood culture system. J Clin Microbiol 1983;18:300-4.

  16. Geha DJ, Roberts GD. Laboratory detection of fungemia. Clin Lab Med 1994;14:83-97.

  17. Lyon R, Wood G. Comparison of BacT/Alert and isolator blood culture systems for recovery of fungi. Am J Clin Pathol 1995;103:660-2.

  18. Smith H, Congdon P. Neonatal systemic candidiasis. Arch Dis Child. 1985;60:365-9.

  19. Baley JE, Kliegeman RJ, Fanaroff AA. Disseminated fungal infections in very-low-birth-weight infants. Clinical manifestations and epidemiology. Pediatrics 1984;73:144-52.

  20. Sánchez LM, Pfaller AM, Cabezudo I, Bale M, Buschelman B. Diagnosis of disseminated candidiasis in hospitalized patients using the Cand-Tec latex agglutination assay. Mycopathologia 1992;118:153-62.

  21. Iwasaki H, Misaki H, Nakamura T, Ueda T. Surveillance of the serum Candida antigen titer for initiation of antifungal therapy after post-remission chemotherapy in patients with acute leukemia. Int J Hemathol 2000;71:266-72.

  22. Obayashi T, Yoshida M, Mori T, Goto H, Yasuoka A, Iwasaki H, Teshima H, Kohno S, Horiuchi A, Ito A, Yamaguchi H, Shimada K, Kawai T. Plasma (1-3)-b-D-glucan measurement in diagnosis of invasive deep mycoses and fungal febrile episodes. Lancet 1995;345:17-20

  23. O´Shaughnessy EM, Shea IM, Witebsky FG. Laboratory Diagnosis of Invasive Mycoses. Infect Dis Clin N Am. 2003;17:135-58.

  24. Vázquez Tsuji O, Campos Rivera T, Coria Lorenzo JJ, Rondán Zárate A. Terapéutica Recomendada en Patógenos Micóticos. En: Terapia Antiinfecciosa en Pediatría. Coria Lorenzo JJ, Gómez Barreto D. Intersistemas Editores. 1a Ed. México 2004;pp139-63.

  25. Ostrosky-Zeichner L, Rex JH, Bennet J, Kullberg BJ. Deeply invasive candidiasis. Infect Dis Clin N Am 2002;16:821-835.

  26. Rex JH, Walsh TJ, Sobel JD, Filler SG, Pappas PG, Dismukes WE, Edwards JE. Practice Guidelines for the Treatment of Candidiasis. Infectious Diseases Society of America. Clin Infect Dis 2000;30:662-78.

  27. Vázquez Tsuji O, Campos Rivera T. Antimicóticos. En: González Saldaña N, Saltigeral Simental P. Antimicrobianos, Antivirales, Antiparasitarios, Antimicóticos e Inmunomoduladores. Ed. Mc Graw Hill. Sexta Edición. México. 2004;pp283-302.

  28. Taketomo KC,Hoding HJ, Kraus MD. Pediatric Dosage Handbook. Lexicomp. USA. 2001;pp430-2.

  29. Anaissie EJ, Darouiche RO, Abi-Said D, Uzun O, Mera J, Centry LO, Williams T, Kontoyiannis DP, Karl Cl, Bodey GP. Management of invasive candidal infections: result of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and review of the literature. Clin Infect Dis 1996;23:964-72.

  30. Rex JH, Bennett JE, Sugar Am, Pappas PG, Van Der Horst ChM, Edwards JE, Washburn RG, Scheld WM, Karchmer AW, Dine AP, Levenstein MJ, Webb CD. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. N Engl J Med 1994;331:1325-30.

  31. Kasten LB, Goldman PM, Gray DL, Aberg AJ. Candida species in Isada MC. Infectious Diseases Handbook. 4th Ed.LEXI-COMP.INC. Hudson Ohio. USA. 200;pp106-8.

  32. Kontoyiannis DP, Luna MA, Samuels BI, Bodey GP. Hepatosplenic candidiasis: a manifestation of chronic disseminated candidiasis. Infect Dis Clin North Am 2000;14:721-39.

  33. Bjerke JW, Meyers JD, Bowden RA. Hepatosplenic candidiasis—a contraindication to marrow transplantation. Blood 1994;84:2811-14.

  34. Kauffman CA, Bradley SF, Ross SC, Weber DR. Hepatosplenic candidiasis: Successful treatment with fluconazole. Am J Med 1991;91:137-41.

  35. Vázquez TO, Cárdenas CR, Gómez SL, Cardoso HG, Campos RT, Martínez BI, García CG. Candidiasis hepato-espleno-renal en un paciente con leucemia aguda linfoblástica. Rev Mex Patol Clín 2000;47:228-34.

  36. Anaissie E, Bodey G, Kantarjian H, David C, Barnett K, Bow E, Defelice R, Downs N, File T, Karam G, Potts D, Shelton M, Sugar A. Fluconazole therapy for chronic disseminated candidiasis in patients with leukemia and prior amphotericin B therapy. Am J Med 1991;91:142-50.

  37. Pestalozzi BC, Krestin GP, Schanz U, Jacky E, Gmür J. Hepatic lesions of chronic disseminated candidiasis may become invisible during neutropenia. Blood 1997;90:3858-64.

  38. Roilides E, Sein T, Schaufele R, Chanock S, Walsh T. Increased serum concentrations of interleukin 10 in patients with hepatoesplenic candidiasis. J Infect Dis 1998;178:589-92.

  39. Semelka R, Kelekis N, Sallah S, Worawattanakul S, Ascher S. Hepatoesplenic fungal disease: Diagnostic accuracy and spectrum of appearance on MR imaging. ARJ 1997;169:1311-6.

  40. Walsh T, Whitcomb P, Revankar S, Pizzo P. Successful treatment of hepatoesplenic candidiasis through repeated cycles of chemotherapy and neutropenia. Cancer 1995;76:2337-62.






>Journals >Acta Pediátrica de México >Year 2006, Issue 1
 

· Journal Index 
· Links 






       
Copyright 2019